ENOV vs IRMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

ENOV

66.9
AI Score
VS
ENOV Wins

IRMD

59.8
AI Score

Investment Advisor Scores

ENOV

67score
Recommendation
HOLD

IRMD

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ENOV IRMD Winner
Forward P/E 4.6404 41.1523 ENOV
PEG Ratio 1.8989 4.46 ENOV
Revenue Growth 3.2% 0.3% ENOV
Earnings Growth 153.1% -9.3% ENOV
Tradestie Score 66.9/100 59.8/100 ENOV
Profit Margin -48.0% 26.7% IRMD
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY IRMD

Relative Price Performance (Last 90 Days)

ENOV 1M: -11.5% · 3M: -19.2% IRMD 1M: -0.8% · 3M: -15.1%

Current Technical Phase

ENOV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 37

RSI (14): 37.2 · Price: $18.17

IRMD

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.3%) with fading momentum, RSI 50

RSI (14): 49.9 · Price: $85.68

Fundamentals Snapshot

Metric ENOV IRMD
Market Cap — —
Forward P/E 4.9 34.8
Trailing P/E — 48.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.8%
Operating Margin 0.0% 0.3%
EPS -19.27 1.79
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, ENOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.